enVVeno Medical Corporation (NVNO:NASDAQ) closed at $7.47 on October 16, 2026, down 5.74% on the day. The stock trades 72.9% below its 52-week high of $27.55 and 6.6% above its 52-week low of $7.01. Over the past year, it lost 71.2%. enVVeno Medical Corporation is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -8.34% | -15.05% | -32.28% | -38.16% | -71.24% |
In 252 trading sessions since October 16, 2025, NVNO closed higher on 121 days (48%). Its best day was January 30, 2026 (+19.18%) and its worst was November 14, 2025 (-35.68%). The stock moved 10% or more in a single session 15 times. It opened at least 5% above the previous day's high 1 time.
enVVeno Medical Corp is a medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its lead product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Find more stocks like NVNO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.